Home NDC 71205-391 acyclovir
Product NDC 71205-391
11-digit product format 712050391
Labeler code 71205
Product ID 71205-391_51052f0e-1a07-405a-a962-981ce9439e02
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form TABLET
Route ORAL
Labeler Proficient Rx LP
Application ANDA077309
Marketing category ANDA
Marketing start 2007-06-09
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 400 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197311
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71205-391-25 71205039125 25 TABLET in 1 BOTTLE (71205-391-25) 25 tablet 2020-01-28 0000-00-00 No No Current 71205-391-30 71205039130 30 TABLET in 1 BOTTLE (71205-391-30) 30 tablet 2020-01-28 0000-00-00 No No Current 71205-391-60 71205039160 60 TABLET in 1 BOTTLE (71205-391-60) 60 tablet 2020-01-28 0000-00-00 No No Current 71205-391-90 71205039190 90 TABLET in 1 BOTTLE (71205-391-90) 90 tablet 2020-01-28 0000-00-00 No No Current